Public annual accounts

DR. STEFAAN BAFORT financials

Name: DR. STEFAAN BAFORT financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DR. STEFAAN BAFORT, with comparable measures and links to available source documents.

Company overview

Registry number

0459642022

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for DR. STEFAAN BAFORT

2025 versus 2024

Operating line: €584,405
EBITDA: €546,755
Total assets: €3,372,768
Equity: €3,330,968

EBITDA margin +93.6% · Equity ratio +98.8%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Jun 2025	€584,405	€546,755	€3,372,768	€3,330,968	-
202430 Jun 2024	€424,463	€427,767	€3,218,373	€3,120,438	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202530 Jun 2025

€584,405

€546,755

€3,372,768

€3,330,968

202430 Jun 2024

€424,463

€427,767

€3,218,373

€3,120,438